BackBrowsing Artículos by Author "Zabala Letona, Amaia"
Now showing items 1-4 of 4
-
Identification of Androgen Receptor Metabolic Correlome Reveals the Repression of Ceramide Kinase by Androgens
; ; ; ; ; ; ; ; ; ; ; ; ; Carracedo Pérez, Arkaitz
(MDPI, 2021-08-26)
Prostate cancer (PCa) is one of the most prevalent cancers in men. Androgen receptor signaling plays a major role in this disease, and androgen deprivation therapy is a common therapeutic strategy in recurrent disease. ... -
PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer
Zabala Letona, Amaia; Arruabarrena Aristorena, Amaia; Fernández Ruiz, Sonia; Viera, Cristina; Carlevaris, Onintza; Ercilla Eguiarte, Amaia; Mendizabal, Isabel; Martín Mateos, Teresa; Macchia, Alice; Camacho Soguero, Laura; Pujana Vaquerizo, Mikel; Sánchez Mosquera, Pilar; Torrano Moya, Verónica; Martín Martín, Natalia; Zuñiga García, Patricia; Castillo Martín, Mireia; Ugalde Olano, Aitziber; Loizaga Iriarte, Ana; Unda Urzaiz, Jesús Miguel; Mato, José M.; Berra Ramírez, Miren Edurne; Martínez Chantar, María Luz; Carracedo Pérez, Arkaitz (Springer Nature, 2022-02)
[EN] Glycine N-Methyltransferase (GNMT) is a metabolic enzyme that integrates metabolism and epigenetic regulation. The product of GNMT, sarcosine, has been proposed as a prostate cancer biomarker. This enzyme is predominantly ... -
Targeting PML in triple negative breast cancer elicits growth suppression and senescence
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Carracedo Pérez, Arkaitz (Nature, 2020-04)
Oncogene addiction postulates that the survival and growth of certain tumor cells is dependent upon the activity of one oncogene, despite their multiple genetic and epigenetic abnormalities. This phenomenon provides a ... -
The PP2A regulator IER5L supports prostate cancer progression
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Carracedo Pérez, Arkaitz (Nature, 2024-07)
Prostate cancer exhibits high prevalence and accounts for a high number of cancer-related deaths. The discovery and characterization of molecular determinants of aggressive prostate cancer represents an active area of ...